Nov 10, 2015 Cellectar Biosciences Converts Patent Application for Phospholipid-Ether Analogs as Cancer Targeting Drug Vehicles Learn More
Nov 5, 2015 Cellectar Biosciences to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Provide Clinical Development Program Update Learn More
Nov 2, 2015 Cellectar Biosciences Provides Phospholipid Drug Conjugate (PDC) Platform Development Update Learn More